Sirio Pharma Co., Ltd. (300791.SZ) — Stock Score Summary

Sirio Pharma Co., Ltd. (300791.SZ) has a MoatMap StockRank of 11/100 based on Quality (38/100), Value (24/100), and Momentum (31/100) factor scores. The current signal is STRONG SELL. Nutraceutical CDMO lacking the high-barrier biologics regulatory moat required for our CDMO pricing power theme.

Sirio Pharma Co., Ltd. is a leading global contract development and manufacturing organization (CDMO) specializing in dietary supplements, including softgels, gummies, and probiotics. The company maintains a strong competitive moat through its extensive international regulatory certifications and advanced formulation capabilities, serving major global health brands. It operates as a vertically integrated, high-quality manufacturer with a significant market share in both Chinese and Western nutraceutical markets.

Key Financial Metrics

Price$2.37
Market Cap$826M
P/E (TTM)43.64
P/E (Forward)8.96
Price/Book1.75
Return on Equity0.2%
Return on Invested Capital2.1%
Debt/Equity60.99
Gross Margin28.5%
Operating Margin9.3%
Revenue Growth5.1%
Dividend Yield0.8%
Free Cash Flow$-167K

Sirio Pharma Co., Ltd. operates in the Packaged Foods industry, part of the Consumer Defensive sector (China).

Frequently Asked Questions

What is Sirio Pharma Co., Ltd.’s (300791.SZ) StockRank?
MoatMap’s StockRank for Sirio Pharma Co., Ltd. (300791.SZ) is 11/100, with a Strong Sell signal. It is a composite of Quality (38), Value (24), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sirio Pharma Co., Ltd. have an economic moat?
Sirio Pharma Co., Ltd. (300791.SZ) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sirio Pharma Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Sirio Pharma Co., Ltd. (300791.SZ) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sirio Pharma Co., Ltd. in?
Sirio Pharma Co., Ltd. (300791.SZ) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (China).
Browse all ranked stocks300791.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock